Form 8-K Vanda Pharmaceuticals For: Feb 16
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
4,710€
2,39%
Echtzeit-Aktienkurs Vanda Pharmaceuticals
Bid:
Ask:
Nachrichten zur Vanda Pharmaceuticals Aktie
Why Vanda Pharmaceuticals Stock Crawled Higher Today
A solid earnings beat drove the companys share price upward....…
Form 10-K Vanda Pharmaceuticals For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vanda Pharmaceuticals GAAP EPS of $0.12 beats by $0.04, revenue of $64.5M misses by $3.1M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
Q4 2022 total revenues were $64.5 million Full year 2022 revenues were $254.4 million Vanda provides update on pipeline advancements…
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results on February 8, 2023
Conference Call and Webcast to Follow WASHINGTON, Feb. 1, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced…
Insights on the Insomnia Global Market to 2028 - Featuring Eisai, Takeda Pharmaceutical, Vanda Pharmaceuticals and Cadila Healthcare Among Others
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Global Insomnia Market Size, Share & Industry Trends Analysis Report by Distribution Channel,…
Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference
WASHINGTON, Jan. 6, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in…
Form 8-K Vanda Pharmaceuticals For: Dec 22
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Vanda Pharmaceuticals For: Dec 14
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vanda Pharmaceuticals Provides an Update to HETLIOZ® ANDA Litigation Appeal: Federal Circuit grants motion to temporarily enjoin generic launch
WASHINGTON, Dec. 16, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provided an update on its appeal of…
Form 8-K Vanda Pharmaceuticals For: Dec 13
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Retail Investors Slamming The Bid Amid Tax-Loss Selling Capitulation
Retail Investors Slamming The Bid Amid Tax-Loss Selling Capitulation
…
Vanda Pharmaceuticals Responds to Ruling in HETLIOZ® ANDA Litigation
WASHINGTON, Dec. 13, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today responded to the ruling in its HETLIOZ®…
Vanda Pharmaceuticals Shares Tumble After Loss in Hetlioz Patent Suit >VNDA
Vanda Pharmaceuticals Shares Tumble After Loss in Hetlioz Patent Suit >VNDA...…
Vanda Pharmaceuticals plunges after loss in Hetlioz patent case
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: President and CEO verkauft Aktien von Vanda Pharmaceuticals im Wert von 512.082$
Polymeropoulos, Mihael Hristos - Vorstand - Tag der Transaktion: 2022-12-06...…
Insiderhandel: President and CEO verkauft Aktien von Vanda Pharmaceuticals im Wert von 506.200$
Polymeropoulos, Mihael Hristos - Vorstand - Tag der Transaktion: 2022-12-05...…
Insiderhandel: SVP, CFO & Treasurer verkauft Aktien von Vanda Pharmaceuticals im Wert von 50.827$
Moran, Kevin Patrick - Vorstand - Tag der Transaktion: 2022-12-06...…
Vanda says performance anxiety drug lowered stress in Phase 2 enrollees
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vanda Pharmaceuticals Announces Participation at November 2022 Investor Conferences
WASHINGTON, Nov. 8, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in…
Vanda Pharmaceuticals (VNDA) Lags Q3 Earnings and Revenue Estimates
Vanda (VNDA) delivered earnings and revenue surprises of -40% and 8%, respectively, for the quarter ended September 2022. Do the…
Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022
Conference Call and Webcast to Follow WASHINGTON, Oct. 26, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced…
Vanda granted FDA’s Orphan Drug Designation for cholera therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VPO-227, a Novel Candidate for the Treatment of Cholera
WASHINGTON, Oct. 21, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the U.S. Food and Drug Administration…
Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the Vanda Securities Litigation
NEW YORK, Oct. 7, 2022 /PRNewswire/ -- UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK KENNETH GORDON, Individually and…
Pound rallies on 45p tax rate U-turn; recession fears mount – business live
Rolling coverage of the latest economic and financial newsPolitics Live: Truss expected to abandon plan to abolish 45% top rate…